Financials
Income statement
| Fiscal date | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total reported revenue | 33.2B | 23.6B | 24.8B | 27.4B |
| Cost of revenue | 16.8B | 9.0B | 11.9B | 11.8B |
| Gross profit | 16.5B | 14.6B | 12.9B | 15.6B |
| Operating expense | ||||
| Research & development | — | 0 | 263K | 832K |
| Selling general and admin | — | 169.1M | 186.7M | 111.8M |
| Other operating expenses | 6.5B | 3.0B | 3.2B | 3.0B |
| Operating income | 4.0B | 4.7B | 3.3B | 6.4B |
| Non operating interest income | ||||
| Income | — | 3.2B | 1.1B | 637.5M |
| Expense | 33.1M | 17.2M | 31.5M | 20.3M |
| Other income expense | — | — | — | — |
| Pretax income | 7.5B | 8.3B | 4.8B | 7.1B |
| Tax provision | 2.0B | 2.2B | 1.3B | 2.1B |
| Net income | 5.5B | 6.1B | 3.5B | 5.0B |
| Basic EPS | 15.0 | 8.4 | 4.8 | 13.6 |
| Diluted EPS | 15.0 | 8.4 | 4.8 | 13.6 |
| Basic average shares | 366.7M | 733.1M | 733.1M | 366.6M |
| Diluted average shares | 366.7M | 733.1M | 733.1M | 366.6M |
| EBITDA | 8.2B | 9.0B | 5.6B | 8.4B |
| Net income from continuing op. | 7.5B | 8.3B | 4.8B | 7.4B |
| Minority interests | — | — | — | — |
| Preferred stock dividends | 0 | 0 | 0 | 0 |